The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Cervical cancer in low and middle‑income countries (Review)
Open accessAbstract
Cervical cancer is a malignant tumour that occurs in the cervix and is classified into two histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more common and accounts for 70% of all cases. In 2018 there were ~569,000 new cases of cervical cancer diagnosed worldwide and ~311,000 deaths were attributed to cervical cancer. Of these, between 84 and 90% occurred in low- and middle-income countries (LMICs) such as South Africa, India, China and Brazil. The most common cause of cervical cancer is persistent infection caused by the sexually transmitted human papilloma virus. Other factors that contribute to the incidence of cervical cancer include geography, traditional practices and beliefs, the screening levels, socioeconomic status, healthcare access, public awareness, use of oral contraceptives, smoking and co-infection with HIV. An estimated 11 million women from LMICs will be diagnosed with cervical cancer in the next 10-20 years. The aim of this review was to explore various types of genetic and epigenetic factors that influence the development, progression or suppression of cervical cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Correspondence - Tranexamic acid for traumatic brain injury
(2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · doi:10.1016/s0140-6736 · Cited by 11,894
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Global causes of maternal death: a WHO systematic analysis
Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A.-B., Daniels, J., Gülmezoglu, A. M., Temmerman, M., & Alkema, L. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70227-x · Cited by 6,582
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
Cohen, P. A., Jhingran, A., Oaknin, A., & Denny, L. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32470-x · Cited by 2,412
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Bray, F., Ren, J., Masuyer, E., & Ferlay, J. (2013) · International Journal of Cancer · doi:10.1002/ijc.27711 · Cited by 1,891
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
Bruni, L., Diaz, M., Castellsagué, X., Ferrer, E., Bosch, F. X., & de Sanjosé, S. (2010) · The Journal of Infectious Diseases · doi:10.1086/657321 · Cited by 1,641
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Function of alternative splicing
Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., & Soreq, H. (2005) · Gene · doi:10.1016/j.gene.2004.10.022 · Cited by 1,377
Chapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Chen, M., & Manley, J. L. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2777 · Cited by 1,284
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Pre-mRNA splicing and human disease
Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,256
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
The global burden of women's cancers: a grand challenge in global health
Ginsburg, O., Bray, F., Coleman, M. P., Vanderpuye, V., Eniu, A., Kotha, S. R., Sarker, M., Huong, T. T., Allemani, C., Dvaladze, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31392-7 · Cited by 1,127
Screening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976
Waggoner, S. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13778-6 · Cited by 844
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747
Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries
Goldie, S. J., Gaffikin, L., Goldhaber-Fiebert, J. D., Gordillo-Tobar, A., Levin, C., Mahé, C., & Wright, T. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa044278 · Cited by 666
Castellsague, X., & Munoz, N. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003477 · Cited by 606
Alternative splicing and disease
Tazi, J., Bakkour, N., & Stamm, S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.017 · Cited by 540
Planning cancer control in Latin America and the Caribbean
Goss, P. E., Lee, B. L., Badovinac-Crnjevic, T., Strasser-Weippl, K., Chavarri-Guerra, Y., Louis, J. S., Villarreal-Garza, C., Unger-Saldaña, K., Ferreyra, M., Debiasi, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70048-2 · Cited by 499
Self-citationComprehensive Control of Human Papillomavirus Infections and Related Diseases
Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A.-B., Gillison, M. L., Doorbar, J., Stern, P. L., Stanley, M., Arbyn, M., Poljak, M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.026 · Cited by 433
The International Collaboration of Epidemiological Studies of Cervical Cancer (2007) · International Journal of Cancer · doi:10.1002/ijc.22357 · Cited by 404
Hasan, U. A., Bates, E., Takeshita, F., Biliato, A., Accardi, R., Bouvard, V., Mansour, M., Vincent, I., Gissmann, L., Iftner, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3186 · Cited by 380
microRNAs: a newly described class of encoded molecules that play a role in health and disease.
Felekkis, K. N., Touvana, E., Stefanou, C., & Deltas, C. C. (2010) · PubMed Central · Cited by 371
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A.-B., Gillison, M. L., Doorbar, J., Stern, P. L., Stanley, M., Arbyn, M., Poljak, M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.003 · Cited by 328
Goodson, W. H., Lowe, L., Carpenter, D. O., Gilbertson, M., Manaf Ali, A., Lopez de Cerain Salsamendi, A., Lasfar, A., Carnero, A., Azqueta, A., Amedei, A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv039 · Cited by 322
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Urban-Wojciuk, Z., Khan, M. M., Oyler, B. L., Fåhraeus, R., Marek-Trzonkowska, N., Nita-Lazar, A., Hupp, T. R., & Goodlett, D. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02388 · Cited by 307
Lu, W., Zhang, H., Niu, Y., Wu, Y., Sun, W., Li, H., Kong, J., Ding, K., Shen, H.-M., Wu, H., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0685-9 · Cited by 302
Cervical cancer prevention: New tools and old barriers
Scarinci, I. C., Garcia, F. A. R., Kobetz, E., Partridge, E. E., Brandt, H. M., Bell, M. C., Dignan, M., Ma, G. X., Daye, J. L., & Castle, P. E. (2010) · Cancer · doi:10.1002/cncr.25065 · Cited by 293
Defining “mutation” and “polymorphism” in the era of personal genomics
Karki, R., Pandya, D., Elston, R. C., & Ferlini, C. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0115-z · Cited by 275
Zheng, J., Huang, X., Tan, W., Yu, D., Du, Z., Chang, J., Wei, L., Han, Y., Wang, C., Che, X., et al. (2016) · Nature Genetics · doi:10.1038/ng.3568 · Cited by 264
Jit, M., Brisson, M., Portnoy, A., & Hutubessy, R. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70237-2 · Cited by 261
Improvement of pathology in sub-Saharan Africa
Adesina, A., Chumba, D., Nelson, A. M., Orem, J., Roberts, D. J., Wabinga, H., Wilson, M., & Rebbeck, T. R. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70598-3 · Cited by 252
Ndejjo, R., Mukama, T., Musabyimana, A., & Musoke, D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149696 · Cited by 230
Lu, W., Zhang, H., Niu, Y., Wu, Y., Sun, W., Li, H., Kong, J., Ding, K., Shen, H.-M., Wu, H., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0716-6 · Cited by 218
TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis
Korneev, K. V., Atretkhany, K.-S. N., Drutskaya, M. S., Grivennikov, S. I., Kuprash, D. V., & Nedospasov, S. A. (2017) · Cytokine · doi:10.1016/j.cyto.2016.01.021 · Cited by 217
Present status of human papillomavirus vaccine development and implementation
Herrero, R., González, P., & Markowitz, L. E. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70481-4 · Cited by 215
Alternative splicing in cancer: Noise, functional, or systematic?
Skotheim, R. I., & Nees, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.016 · Cited by 208
Gelband, H., Sankaranarayanan, R., Gauvreau, C. L., Horton, S., Anderson, B. O., Bray, F., Cleary, J., Dare, A. J., Denny, L., Gospodarowicz, M. K., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00755-2 · Cited by 205
Hasan, U. A., Zannetti, C., Parroche, P., Goutagny, N., Malfroy, M., Roblot, G., Carreira, C., Hussain, I., Müller, M., Taylor-Papadimitriou, J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122394 · Cited by 191
Raine, R., Fitzpatrick, R., Barratt, H., Bevan, G., Black, N., Boaden, R., Bower, P., Campbell, M., Denis, J.-L., Devers, K., et al. (2016) · Health Services and Delivery Research · doi:10.3310/hsdr04160 · Cited by 186
Cervical cancer control in HIV-infected women: Past, present and future
Ghebre, R. G., Grover, S., Xu, M. J., Chuang, L. T., & Simonds, H. (2017) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2017.07.009 · Cited by 177
Association between toll‐like receptor expression and human papillomavirus type 16 persistence
Daud, I. I., Scott, M. E., Ma, Y., Shiboski, S., Farhat, S., & Moscicki, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25400 · Cited by 169
Cervical cancer screening and treatment in Uganda
Nakisige, C., Schwartz, M., & Okoth, A. (2017) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2017.01.009 · Cited by 159
Origin of Spliceosomal Introns and Alternative SplicingPreprint
Irimia, M., & Roy, S. W. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016071 · Cited by 155
A functional lncRNA HOTAIR genetic variant contributes to gastric cancer susceptibility
Pan, W., Liu, L., Wei, J., Ge, Y., Zhang, J., Chen, H., Zhou, L., Yuan, Q., Zhou, C., & Yang, M. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22261 · Cited by 146
Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications
Sartorius, K., Sartorius, B. K. D., Aldous, C. R., Govender, P., & Madiba, T. E. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.04.006 · Cited by 139
Alternative transcription and alternative splicing in cancer
Pal, S., Gupta, R., & Davuluri, R. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.005 · Cited by 129
Understanding cervical screening non-attendance among ethnic minority women in England
Marlow, L. A. V., Wardle, J., & Waller, J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.248 · Cited by 124
Cervical cancer prevention and treatment in Latin America
Varón, M. L., Baker, E., Maza, M., Fontes‐Cintra, G., López, A., Carvajal, J. M., Nozar, F., Fiol, V., & Schmeler, K. M. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24544 · Cited by 114
Liu, F., Dai, M., Xu, Q., Zhu, X., Zhou, Y., Jiang, S., Wang, Y., Ai, Z., Ma, L., Zhang, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0119-6 · Cited by 113
The role of TLRs in cervical cancer with HPV infection: a review
Yang, X. Y., Cheng, Y., & Li, C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.55 · Cited by 105
Groß, K., Schellenberg, J., Kessy, F., Pfeiffer, C., & Obrist, B. (2011) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-11-36 · Cited by 103
MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
Fan, Z., Cui, H., Yu, H., Ji, Q., Kang, L., Han, B., Wang, J., Dong, Q., Li, Y., Yan, Z., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.1 · Cited by 93
Levin, A., Wang, S. A., Levin, C., Tsu, V. D., & Hutubessy, R. C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101114 · Cited by 91
Self-citationmiR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer.
Zhu, Y., Wu, G., Yan, W., Zhan, H., & Sun, P. (2017) · Europe PMC (PubMed Central) · Cited by 91
Mbulawa, Z. Z. A., Coetzee, D. J., & Williamson, A. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1181-8 · Cited by 90
Toll-Like Receptor Transcriptome in the HPV-Positive Cervical Cancer Microenvironment
DeCarlo, C. A., Rosa, B. A., Jackson, R., Niccoli, S., Escott, N. G., & Zehbe, I. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/785825 · Cited by 87
Kunckler, M., Schumacher, F., Kenfack, B., Catarino, R., Viviano, M., Tincho, E., Tebeu, P. M., Temogne, L., Vassilakos, P., & Petignat, P. (2017) · Cancer Medicine · doi:10.1002/cam4.1089 · Cited by 80
Tumor-suppressing roles of miR-214 and miR-218 in breast cancer
LIU, B., Tian, Y., Li, F., Zhao, Z., Jiang, X., Zhai, C., Han, X., & Zhang, L. (2016) · Oncology Reports · doi:10.3892/or.2016.4749 · Cited by 79
Molecular methods for identification and characterization of novel papillomaviruses
Kocjan, B. J., Bzhalava, D., Forslund, O., Dillner, J., & Poljak, M. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.05.011 · Cited by 78
Provision of Antiretroviral Therapy in South Africa: The Nuts and Bolts
Bekker, L., Venter, F., Cohen, K., Goemare, E., Cutsem, G. V., Boulle, A., & Wood, R. (2013) · Antiviral Therapy · doi:10.3851/imp2905 · Cited by 75
Signaling Pathways Driving Aberrant Splicing in Cancer Cells
Gonçalves, V., Pereira, J., & Jordan, P. (2017) · Genes · doi:10.3390/genes9010009 · Cited by 71
Cervical cancer in Tanzania: A systematic review of current challenges in six domains
Runge, A. S., Bernstein, M. E., Lucas, A. N., & Tewari, K. S. (2019) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2019.05.008 · Cited by 71
The present scenario of cervical cancer control and HPV epidemiology in India: an outline.
Senapathy, G. J., Umadevi, P., & Kannika, P. S. (2011) · PubMed · Cited by 70
Prevalence of human papillomavirus types in cervical and oral cancers in central India
Gheit, T., Vaccarella, S., Schmitt, M., Pawlita, M., Franceschi, S., Sankaranarayanan, R., Sylla, B. S., Tommasino, M., & Gangane, N. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.11.041 · Cited by 68
miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200
Wang, F., Shu, S., Li, Y., Endong, Z., Lirong, Y., & Sun, B. (2016) · Scientific Reports · doi:10.1038/srep33229 · Cited by 67
Velema, J. P., Ferrera, A., Figueroa, M., Bulnes, R., Toro, L. A., de Barahona, O., Claros, J. M., & Melchers, W. J. G. (2001) · International Journal of Cancer · doi:10.1002/ijc.1622 · Cited by 66
Hasim, A., Lin, G., Li, Q., Zhang, R.-P., & Guo, X. (2011) · 癌症:英文版 · doi:10.5732/cjc.010.10456 · Cited by 63
Clinical implications of the interaction between HPV and HIV infections
Dreyer, G. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.011 · Cited by 61
Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review
Mehta, A., Mooij, M., Branković, I., Ouburg, S., Morré, S. A., & Jordanova, E. S. (2017) · Journal of Immunology Research · doi:10.1155/2017/8913860 · Cited by 60
Multifactorial etiology of cervical cancer: a hypothesis.
Haverkos, H. W. (2005) · PubMed · Cited by 59
Moving Forward in HIV-Associated Cancer
Gopal, S., Achenbach, C. J., Yanik, E. L., Dittmer, D. P., Eron, J. J., & Engels, E. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.1376 · Cited by 56
Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility
Pandey, N. O., Chauhan, A. V., Raithatha, N. S., Patel, P. K., Khandelwal, R., Desai, A. N., Choxi, Y., Kapadia, R. S., & Jain, N. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-46077-z · Cited by 56
Toll-Like Receptors in Human Papillomavirus Infection
Zhou, Q., Zhu, K., & Cheng, H. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0220-7 · Cited by 55
Liao, J., Lin, J., Lin, D. X., Zou, C., Kurata, J. S., Lin, R.-J., He, Z., & Su, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00901-6 · Cited by 54
An integrative framework identifies alternative splicing events in colorectal cancer development
Bisognin, A., Pizzini, S., Perilli, L., Esposito, G., D, S. M. M., Nitti, D., Zanovello, P., Bortoluzzi, S., & Mandruzzato, S. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.10.004 · Cited by 53
HPV and Cervical Cancer Epidemiology - Current Status of HPV Vaccination in India
Chatterjee, S., & Chattopadhyay, A. (2016) · APJCP · doi:10.14456/apjcp.2016.154 · Cited by 52
Fujiki, H. (2013) · Cancer Science · doi:10.1111/cas.12333 · Cited by 49
Visual Inspection With Acetic Acid in Cervical Cancer Screening
Ardahan, M., & Temel, A. B. (2010) · Cancer Nursing · doi:10.1097/ncc.0b013e3181efe69f · Cited by 46
Chen, Z., Wang, M., He, Q., Li, Z., Zhao, Y., Wang, W., Ma, J., Li, Y., & Chang, G. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4171 · Cited by 46
Zolini, G. P., Lima, G. K., Lucinda, N., Silva, M. A., Dias, M. F., Pessoa, N. L., Coura, B. P., Cartelle, C. T., Arantes, R. M. E., Kroon, E. G., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-20 · Cited by 44
miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer
Lu, Q., Xu, L., Li, C., Yuan, Y., Huang, S., & Chen, H. (2016) · Tumor Biology · doi:10.1007/s13277-016-5320-7 · Cited by 44
Prevention of Cervix Cancer in India
Mishra, G. A., Pimple, S. A., & Shastri, S. S. (2016) · Oncology · doi:10.1159/000447575 · Cited by 41
Mattheij, I., Pollock, A. M., & Brhlíková, P. (2012) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2012.110343 · Cited by 40
Olsson, E., Lau, M., Lifvergren, S., & Chakhunashvili, A. (2014) · International Journal for Equity in Health · doi:10.1186/s12939-014-0062-x · Cited by 39
The HOTAIR, PRNCR1 and POLR2E polymorphisms are associated with cancer risk: a meta-analysis
Chu, H., Chen, Y., Yuan, Q., Hua, Q., Zhang, X., Wang, M., Tong, N., Zhang, W., Chen, J., & Zhang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.14920 · Cited by 39
Idehen, E. E., Korhonen, T., Castaneda, A. E., Juntunen, T., Kangasniemi, M. K., Pietilä, A., & Koponen, P. (2017) · BMC Women s Health · doi:10.1186/s12905-017-0375-1 · Cited by 37
Prevalence of human papillomavirus types in cervical lesions from women in rural Western India
Deodhar, K., Gheit, T., Vaccarella, S., Romao, C. C., Tenet, V., Nene, B. M., Jayant, K., Kelkar, R., Malvi, S. G., Sylla, B. S., et al. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23310 · Cited by 34
Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective
Lorenzi, A. T., Syrjänen, K. J., & Longatto‐Filho, A. (2015) · Virology Journal · doi:10.1186/s12985-015-0342-0 · Cited by 33
McCree, R., Giattas, M. R., Sahasrabuddhe, V. V., Jolly, P. E., Martin, M. Y., Usdan, S., Kohler, C. L., & Lisovicz, N. F. (2015) · The Oncologist · doi:10.1634/theoncologist.2013-0305 · Cited by 32
Evidence-based improvisation: Facing the challenges of cervical cancer care in Uganda
Swanson, M. L., Ueda, S. M., Chen, L.-M., Huchko, M. J., Nakisige, C., & Namugga, J. (2018) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2017.12.005 · Cited by 32
miR‐376c inhibits cervical cancer cell proliferation and invasion by targeting BMI 1
Deng, Y., Xiong, Y., & Liu, Y. (2016) · International Journal of Experimental Pathology · doi:10.1111/iep.12177 · Cited by 25
microRNA‑214 suppresses the growth of cervical cancer cells by targeting EZH2
Yang, Y., Liu, Y., Li, G., Li, L., Geng, P., & Song, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.9363 · Cited by 25
Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma
Yu, G., Wang, J., Xu, K., & Dong, J. (2016) · Bioscience Reports · doi:10.1042/bsr20160062 · Cited by 24
microRNA-664 enhances proliferation, migration and invasion of lung cancer cells
Zhu, X., Ju, S., Yuan, F., Chen, G., Shu, Y. L., Li, C., Xu, Y., Luo, J., & Xia, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4433 · Cited by 23
TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16INK4a protein expression
Parroche, P., Roblot, G., Calvez‐Kelm, F. L., Tout, I., Marotel, M., Malfroy, M., Durand, G., McKay, J., Ainouze, M., Carreira, C., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.49 · Cited by 22
Xia, D., Li, X., Niu, Q., Liu, X.-S., Xu, W., Ma, C., Gu, H., Liu, Z., Shi, L., Tian, X., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5447 · Cited by 22
Who Regional Office for Europe (2015) · Cited by 21
Pista, Â., Oliveira, C., Cunha, M. J., Paixão, M. T., & Real, O. (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.03.028 · Cited by 20
SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer
Tian, J., Liu, Y., Zhu, B., Tian, Y., Zhong, R., Chen, W., Lu, X., Zou, L., Shen, N., Qian, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5647 · Cited by 19
PCR-RFLP assay as an option for primary HPV test
Golfetto, L., Alves, E. V., Martins, T. R., Sincero, T. C. M., Castro, J. B. S., Dannebrock, C., de Oliveira, J. G., Levi, J. E., Onofre, A. S. C., & Bazzo, M. L. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20177098 · Cited by 18
Fehri, E., Ennaifer, E., Ardhaoui, M., Ouerhani, K., Laassili, T., Rhouma, R. B. H., Guizani, I., & Boubaker, S. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.15.6145 · Cited by 17
Human papilloma virus: global research architecture assessed by density-equalizing mapping
Brüggmann, D., Kayser, L., Jaque, J. M., Bundschuh, M., Klingelhöfer, D., & Groneberg, D. A. (2018) · Oncotarget · doi:10.18632/oncotarget.25136 · Cited by 16
Co-carcinogenesis: Human Papillomaviruses, Coal Tar Derivatives, and Squamous Cell Cervical Cancer
Haverkos, H. W., Haverkos, G. P., & O’Mara, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02253 · Cited by 15
Chen, X., Du, H., Liu, B., Zou, L., Chen, W., Yang, Y., Zhu, Y., Gong, Y., Tian, J., Li, F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130377 · Cited by 14
Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates
Ginindza, T. G., & Sartorius, B. K. D. (2018) · BMC Cancer · doi:10.1186/s12885-018-4540-1 · Cited by 12
Jacobson, G. M., Chuang, L. T., & Pankow, M. (2018) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2018.06.006 · Cited by 11
Chatzistamatiou, Κ. (2013) · World Journal of Obstetrics and Gynecology · doi:10.5317/wjog.v2.i3.53 · Cited by 9
Chibwesha, C. J., Goeieman, B., Levin, S., Mulongo, M., Faesen, M., Swarts, A., Ramotshela, S., Williams, S. T., Rakhombe, N., Bruce, S., et al. (2018) · South African Medical Journal · doi:10.7196/samj.2017.v108i3.12627 · Cited by 7
Kaur, G., & Sethi, R. S. (2019) · Journal of Occupational Health · doi:10.1002/1348-9585.12094 · Cited by 6
Cited by
Colzani, E., Johansen, K., Johnson, H., & Pastore Celentano, L. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.50.2001659 · Cited by 86
Xu, M., Choi, J., Capasso, A., & DiClemente, R. (2024) · Adolescent Health, Medicine and Therapeutics · doi:10.2147/ahmt.s394119 · Cited by 30
Vahabi, M., Mishra, G., Pimple, S., Wong, J. P.-H., Khan, M., Prakash, V., Anand, K., Narushima, M., & Lofters, A. K. (2023) · BMC Public Health · doi:10.1186/s12889-023-15602-1 · Cited by 29
Cervical cancer screening invitations in low and middle income countries: Evidence from Armenia
Antinyan, A., Bertoni, M., & Corazzini, L. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113739 · Cited by 18
Maheshwari, V., Girotra, S., Malik, M., & Basu, S. (2025) · Cancer Research, Statistics, and Treatment · doi:10.4103/crst.crst_99_24 · Cited by 7
Metadata
- Authors
- Hull, R., Mbele, M., Makhafola, T., Hicks, C., Wang, S., Reis, R., Mehrotra, R., Mkhize‑Kwitshana, Z., Kibiki, G., Bates, D., & Dlamini, Z.
- Venue
- Oncology Letters
- Publisher
- Spandidos Publications
- Published
- 2020-06-19
- Volume
- 20
- Issue
- 3
- Pages
- 2058-2074
- ISSN
- 1792-1074 (ISSN-L)
- 1792-1082
- OpenAlex
- W3036318564
- Cited by
- 544
- References
- 122
- FWCI
- 28.57
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.